Uji, Japan

Kazunori Tsubaki

This inventor holds 10 USPTO granted patents. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1991-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazunori Tsubaki. Retrieved from https://idiyas.com/inventor/kazunori-tsubaki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.1

ph-index = 3

Forward Citations = 56(Granted Patents)


Location History:

  • Ikeda, JP (1991 - 1993)
  • Suita, JP (1993 - 1995)
  • Uji, JP (1998 - 2002)

Company Filing History:


Years Active: 1991-2002

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Kazunori Tsubaki: Innovator in Pharmaceutical Chemistry

Introduction

Kazunori Tsubaki is a prominent inventor based in Uji, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds. With a total of 10 patents to his name, Tsubaki has established himself as a key figure in his industry.

Latest Patents

Among his latest patents are innovations related to propanolamine derivatives and heterocyclic compounds. These compounds are characterized by their unique structures and potential applications in various therapeutic areas. His work continues to push the boundaries of pharmaceutical research.

Career Highlights

Tsubaki is currently employed at Fujisawa Pharmaceutical Company, Ltd., where he applies his expertise to advance the company's research initiatives. His career is marked by a commitment to innovation and excellence in pharmaceutical development.

Collaborations

Throughout his career, Tsubaki has collaborated with notable colleagues, including Kiyoshi Taniguchi and Kouji Hattori. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Kazunori Tsubaki's contributions to pharmaceutical chemistry are noteworthy, and his ongoing work promises to yield further advancements in the field. His dedication to innovation continues to inspire those around him.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…